Keyphrases
Center of Excellence
66%
Copenhagen
66%
Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
50%
Mixed Neuroendocrine-non-neuroendocrine Neoplasm
40%
Chromogranin A
37%
Large Cell Neuroendocrine Carcinoma (LCNEC)
33%
Prognostic Marker
33%
Lymph Node Metastasis
33%
Confidence Interval
33%
Neuroendocrine Neoplasms
33%
Gastroenteropancreatic
33%
Immunostaining
33%
Bronchopulmonary Neuroendocrine Tumors
33%
Primary Tumor
33%
Typical Carcinoid
33%
Atypical Carcinoid
33%
Somatostatin Receptor 2 (SSTR2)
33%
Tumor
25%
Disease-free Survival
20%
Ki-67 Index
20%
Right-sided
20%
Hemicolectomy
20%
Median Overall Survival
16%
Overtreatment
13%
ENet
13%
Appendectomy
13%
R0 Resection
12%
Strongly Positive
11%
Tumor Subtype
11%
Well-differentiated
11%
FDG PET-CT
11%
Age at Diagnosis
10%
Overall Survival
9%
Cox Regression
9%
Synaptophysin
9%
Working Diagnosis
7%
Small Cell Lung Cancer
7%
Retrospective Collection
6%
Tumor Size
6%
Resection Margin
6%
Serotonin
6%
Median Range
6%
Neuroendocrine Tumor
6%
Positive Resection Margin
6%
Undertreatment
6%
Recurrence Risk
6%
Colon Adenocarcinoma
6%
Tumor Center
6%
No Recurrence
6%
Appropriate Management
6%
Medicine and Dentistry
Neuroendocrine Tumor
100%
Carcinoid
40%
Neoplasm
35%
Primary Tumor
33%
Lymph Node Metastasis
33%
Vermiform Appendix
33%
Hemicolectomy
20%
Large Cell Neuroendocrine Carcinoma
16%
Recurrent Disease
15%
Disease Free Survival
15%
Overall Survival
15%
Surgical Margin
13%
Appendectomy
13%
Surgery
10%
Adenocarcinoma
6%
Serotonin
6%
Goblet Cell
6%
Glucagon
6%
Progression Free Survival
6%
Positron Emission Tomography-Computed Tomography
5%
